Events
Important ideas for the entire health market
Name: MEDICA LABMED FORUM Location: Düsseldorf, Germany Date: 13–16 November 2023 Web:
medica-tradefair.com/en/ Report: Preview
t the MEDICA LABMED FORUM, held as part of MEDICA 2023 in Düsseldorf from 13–16 November, discussions will revolve around a number of pressing healthcare topics. These include cancer, coronary diseases, infections, the rise of new antibacterial substances, digitalisation and artificial intelligence. The forum, a standout feature of the global health and medical technology trade fair, features daily scientific programmes from 10:30am to 04:00pm. These programmes are known for their clear and concise presentations followed by in-depth panel discussions. Organised by Professor Stefan Holdenrieder and Professor Georg Hoffmann (German Heart Centre at the Technical University of Munich), the event also offers exhibiting companies the opportunity to introduce themselves during lunch breaks. The four-day event covers a range of themes, including the impact of the In-Vitro Diagnostics Regulation (IVDR) on small IVD companies, the role of artificial intelligence in laboratories, advances in clinical diagnostics, insights from young scientists and innovations from an industry perspective. These discussions shed light on the evolving landscape of healthcare and medical technology.
A
Though the topics are complex, it is a hallmark of the MEDICA LABMED FORUM that all presentations are short, to the point and easy to understand, and can be addressed in further depth in panel discussions.
Day One: Lab management On Monday, MEDICA starts with two ‘scandalous’ issues which currently cause heated debates throughout the field of laboratory medicine: the potential threat to the existence of small IVD companies and specialised labs posed by the IVDR and the use of artificial intelligence (AI), with new possibilities and also risks. Led by Professor Astrid Petersmann (University of Oldenburg), in the morning there will be a professional discussion concerning the challenges posed by the new EU
Practical Patient Care /
www.practical-patient-care.com
directive for the quality assurance of diagnostic tests, and how these can be overcome. In the afternoon, an equally exciting discussion will follow, concerning how AI and machine learning are about to change the way we work in laboratories. One of the most advanced application areas currently is the automatic evaluation of microscopic images and complex data sets – for example in the diagnosis of leukaemia.
Day Two: Advances in clinical diagnostics On the second day, led by Professor Holdenrieder of the German Heart Centre Munich, there will be a discussion of new developments in laboratory medicine within the fields of oncology and cardiology. Over the past several years, research has revealed the enormous potential of blood examinations for the diagnosis, prognostication and therapy management of different types of cancer. For example, circulating tumour cells and nucleic acids are becoming established as a second methodological pillar, which opens up new perspectives beyond the classic examination of tissue for the field of oncology.
55
A glimpse of the exhibition floor from MEDICA 2022.
Messe Düsseldorf
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61
